← All trials
NCT02118337
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 19, 2014
- Primary completion
- Jul 8, 2019
- Completion date
- Jul 8, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 96
- Arms / groups
- 8 / —
- Source
- AACT · pre-existing
Sponsors
- MedImmuneLead sponsor
- University of WashingtonOverall official - principal investigator
- Mayo ClinicOverall official - principal investigator
- Cornell UniversityOverall official - principal investigator
- The Angeles ClinicOverall official - principal investigator
- Medical University of South CarolinaOverall official - principal investigator
- Providence Health & ServicesOverall official - principal investigator
- University of South FloridaOverall official - principal investigator
- Brown UniversityOverall official - principal investigator
- Rutgers UniversityOverall official - principal investigator
- Pennsylvania State UniversityOverall official - principal investigator
- University of OklahomaOverall official - principal investigator
- West Virginia UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.